Several influenza A strains and recombinants of fowl plague virus (FPV) with a known gene constellation were tested for amantadine sensitivity under two different experimental conditions. In a haemagglutinin yield analysis of a single growth cycle experiment FPV was found to be highly sensitive to amantadine, while in the plaque reduction and inhibition test it was highly resistant. With the A3 Hong Kong and equi 2 strains the opposite observation was made. The A2 Singapore strain was sensitive while Ao PR8 was resistant in both tests. In the haemagglutinin yield analysis of a single growth cycle all recombinants carrying segment 4 (HA) of the resistant strain were resistant against amantadine, independent of the derivation of the other genes. In the plaque reduction and inhibition test recombinants carrying the haemagglutinin of the sensitive strain were either resistant or sensitive depending on the gene constellation. Drug sensitivity was transferred by the combination of segments 5 (NP) and 6 (NA). Segment 7 (M) of certain sensitive strains seems to counteract this effect. The results are compatible with the concept that amantadine resistance or sensitivity is not confined to a single gene product or a single mechanism.
INTRODUCTION
The multiplication of several influenza A virus strains can be inhibited by amantadine 0-adamantanamine) in vivo as well as in vitro, while other strains are resistant (Davies et al. I964; Neumayer et al. I965) . The drug interferes with an early step of virus replication, presumably with uncoating (Kato & Eggers, I969; Dourmashkin & TyrreU, I974; Skehel et al. I977) . Amantadine-resistant variants can be isolated by passaging sensitive strains in the presence of the drug (Cochran et al. I965; Oxford et al. I97o) and this property can be transferred genetically between influenza viruses (Tuckova et al. I973; Appleyard & Maber, I975) . Recently, Appleyard (I977) has shown that amantadine resistance was not connected with the virus haemagglutinin or neuraminidase alone. We explored the following questions: (i) is there a single gene product other than haemagglutinin or neuraminidase responsible for amantadine resistance; (ii) is there a certain constellation of gene products involved? These questions can be tackled by investigating recombinants of known gene constellation between an amantadine-sensitive and an amantadine-resistant strain.
Furthermore, we investigated two different methods of measuring amantadine resistance:
(i) in a haemagglutinin yield analysis of a single growth cycle experiment, the virus yield was measured 8 h post infection (p.i.) in the presence of the drug; and (ii) in a multiple cycle experiment-this is the more usual plaque test (Appleyard & Maber, I975) -the drug was added to the agar overlay medium.
METHODS
Influenza strains and recombinants. The following influenza strains were investigated: fowl plague virus (FPV), strain 'Rostock' (HavlNI); A/turkey/England/63 (HavlNav3); virus N (A/chick/Germany/N/49, Hav2Neqi); equi 2 (A/equine/Miami/I/63, Heq2Neq2); Ao PR8 (A/PR/8/34, HoNI); A2 Singapore (A/Singapore/I/57, H2N2); A2 England (A/England/i/6i, H2N2); A3 Hong Kong (A/Hong Kong/I/68, H3N2 ).
The following ts mutants were investigated for the production of recombinants: ts mutants (the gene carrying the ts defect and segment number in parenthesis) of FPV were ts 3 (Pol i, i), ts 9o (Ptra, 2), ts 263 (Pol 2, 3), ts 227 (HA, 4), ts 19 (NP, 5), ts 81 (NP, 5) and ts 1I 3 (NA, 6) (Scholtissek & Bowles, 1975; Scholtissek et al. 1976) . Ts 412 is a ts mutant obtained by mutagenesis of a recombinant between FPV and virus N carrying the Ptra and NS gene (segment 8) of virus N (9o N, 3; Scholtissek et al. 1976 ). This ts mutant has a defect in the gene coding for the non-structural (NS, 8) protein (I. Koennecke et al. unpublished results). The ts mutant of Ao PR8 (ts 1 I6) has been obtained by mutagenesis of Ao PR8 with 5-fluorouracil (Simpson & Hirst, 1968 ) and by picking plaques on chick embryo cells in the presence of trypsin (Appleyard & Maber, I974; Klenk et al. 1975) at 33 °C at random. Ts 116 was one of the isolates which formed plaques readily at 33 ° C but not at 4o °C. This ts mutant has not yet been fully characterized; however, from rescue experiments with the ts mutants of FPV it is clear that the ts lesion(s) is not located in the Ptra, Pol 2, HA, NP or NA genes. All ts mutants, except 227, exhibited the same sensitivity against amantadine as the parent strains. Most of the recombinants with Ao PRS, A2 Singapore, equi 2 and A3 Hong Kong were prepared by rescue of the ts mutants with other prototype strains under restrictive conditions (Scholtissek et al. I976) . (They are marked by an asterisk.) The other recombinants, except those of turkey England, were obtained by double infection of chick embryo cells with two influenza A strains and selection by specific antisera (Flehmig et al. 1976; Rott et al. 1976 ) . Recombinants with turkey England were isolated after double infection and by picking plaques at random (Rott et al. I979) . If not otherwise stated, only plaque-purified samples were used in the various tests.
Tissue cultures. Most experiments were performed on primary chick embryo cells. Since several of the recombinants formed plaques only on MDCK cells but not on chick embryo cells (Scholtissek et al. I978) , MDCK cells were used occasionally. There was no difference in amantadine sensitivity or resistance detectable in the two cell types when recombinants or prototype strains were tested which grew equally well in both host cells.
Haemagglutinin yieM analysis of a single growth cycle. Virus growth in a single cycle was measured in chick embryo cells 48 h after seeding, by inoculation with a m.o.i, of IO to 5o. The haemagglutination (HA) titre was determined 8 h p.i. in the supernatant fluid after three cycles of freezing and thawing and removal of the cell debris by low speed centrifugation. Amantadine (0"5 to IO #g/ml) was added 30 min before inoculation, remained during adsorption for 3o min and was added to the supernatant medium after removal of the unadsorbed virus by two washings with PBS. In the following, this test is called the single cycle experiment in contrast to the plaque reduction and inhibition test (multiple cycle).
Plaque reduction and inhibition test. Amantadine (I to 5o #g/ml) was added either 3o min before and during inoculation and was also included in the overlay medium, or was only included in the overlay medium. The amantadine hydrochloride was obtained from Sigma. 
RESULTS

Dose response of amantadine on various influenza A strains
First, the sensitivity against amantadine of the various influenza strains used in our laboratory was investigated in the single cycle experiment. As shown in Fig. I , FPV is the most sensitive strain, while Ao PRS, equi 2 and A3 Hong Kong are relatively resistant. Virus N is somewhat less resistant; however, it can be used for comparative studies with FPV. The A2 Singapore and swine influenza strains were found to be as sensitive as FPV. Therefore, recombinants of these strains were not investigated in this test. The turkey England strain turned out to be a highly resistant strain (not shown here).
In other experiments with FPV, in which the HA titre without using amantadine was fourfold higher (5IX HA units), some residual haemagglutinin (2 to 4 HA units) was synthesized after infection even in the presence of io #g/ml amantadine. When this virus was passaged once more under the same conditions and then grown in eggs, the yield was as resistant as the other strains. If FPV from single plaques of the original stock was used, in most experiments some haemagglutinin was produced in the presence of IO #g/ml amantadine. After two further passages in the presence of amantadine, this residual virus propagated in chicken embryos was as sensitive to amantadine as the original stock. This indicates that in the original stock some amantadine-resistant particles were present, which overgrow the otherwise sensitive particles, although the drug does not inhibit the multiplication of the sensitive FPV totally. This is in accordance with recent findings by Appleyard (2977) .
Employing the plaque reduction and inhibition test it was found that the FPV strain was highly resistant to amantadine, while the A3 Hong Kong and equi 2 strains were sensitive (Table I ). For FPV it was observed that with low doses of amantadine the plaque size of FPV was reduced and the plaque number decreased by a factor of about l o. However, with increasing doses of the drug, the plaque size as well as number increased again. This is shown in Table 2 . The plaque size in the presence of a relatively large dose of amantadine exceeded even that without the drug in one experiment (not shown). Trypsin in the overlay agar medium did not influence the plaque size. An explanation for this phenomenon cannot be given. With the sensitive strains equi 2, A2 England or A3 Hong Kong the plaque number decreased at least Ioo-fold even with very low doses (I #g/ml) of amantadine and in the presence of larger doses they never reappeared. The turkey England strain formed only * A resistant strain exhibits a plaque reduction by a maximum factor xo, while with sensitive strains the plaque reduction was at least by a factor of IOOO in the presence of I/zg/ml amantadine.
~" Tiny plaques. 
Sensitivity of recombinants against amantadine in the single cycle test
The various recombinants as listed in Table 3 were grown in the presence of at least two different doses of amantadine (0"5 to IO #g/ml) in order to obtain clear-cut results of their sensitivity against the drug in the single cycle experiment. A sensitive recombinant on the average of three experiments is inhibited at least 64-fold (--), while the resistant recombinants were inhibited maximally fourfold (+÷) with 0"5 #g/ml amantadine. With virus N and weakly resistant recombinants intermediate values (+) of eightfold (0"5/zg/ml) to 32-fold 0o/zg/ml) were found. Resistance to amantadine was never transferred by the segments I (Pol I), 2 (Ptra), 3 (Pol 2), 5 (NP), 6 (NA) or 8 (NS) alone or in most of the combinations of them (Table 3 )-All recombinants carrying the haemagglutinin gene of the resistant virus were found to be resistant to amantadine. RNA segment 7 (M)-at least as long as it is not in combination with RNA segment 4 (HA)-seems to be without influence. The combination of RNA segments 3 and 5 is rather ineffective in transferring resistance but can be influenced by other RNA segments co-transferred, e.g. when segments 3 and 5 of FPV were replaced by the corresponding segments of virus N a weak resistance against amantadine (a drop of 3 to 5 logs HA units) was found. Combined transfer of On: Thu, 29 Nov 2018 13:17:23 Table 3 . Table 4 . t + • at 50/~g/ml amantadine, x to IO % of tiny clear plaques when compared with plaques of untreated cells; -, at 20 or 50 #g/ml amantadine, about x % of turbid small plaques when compared with plaques of untreated cells (see footnote to Table 3 ).
Sensitivity of recombinants between FPV and other influenza A strains to amantadine as tested in the single cycle experiment with segments not derived from FPV l&ted
Sensitivity of recombinants between FPV and other influenza A strains against amantadine as tested by the plaque reduction and inhibition test
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On: Thu, 29 Nov 2018 13:17:23 segments 2 or 8, or I, 2 and 8, or 2, 6 and 8 resulted in recombinants which were as sensitive as FPV. The recombinants in which RNA segments 2, 3, 5 and 8 were derived from Ao PR8 exhibited weak resistance, while the corresponding recombinant of virus N was as sensitive as FPV. However, the prototype Ao PR8 was more resistant than virus N in any case. Therefore it is not clear whether there are strain specificities in this respect. The two recombinants with virus N, in which RNA segment 4 in combination with other segments were derived from virus N, were extremely resistant to amantadine. A drug concentration of o, 5 #g/ml had no effect and Io/zg/ml reduced the HA yield only twofold. Thus these recombinants are much more resistant than either of the strains used for recombination.
Sensitivity of recombinants to amantadine in the plaque reduction and inhibition test
The sensitivity of various recombinants to amantadine in the plaque reduction and inhibition test are summarized in Table 4 . Recombinants between the resistant FPV strain and the sensitive strains A2 England, A2 Singapore, A 3 Hong Kong, turkey England and equi 2 were investigated. Here again at least two different doses of amantadine (I and 20 #g/ml, or I and 50 #g/ml), in most cases three different doses 0, 5 and 20 #g/ml), were tested. As shown, for example with the recombinant V3 in Table 2 , at low doses, size and number of plaques decreased considerably, while with high doses they increased again (+). The data obtained with all recombinants in the plaque reduction and inhibition test were not as clear-cut as found in the single cycle experiment. Nevertheless, there seems to be a different correlation between gene constellation and transfer of resistance when compared with the single cycle test. Many recombinants in which segment 6 (NA) is derived from the sensitive strain, especially in combination with segment 5 (NP), were relatively sensitive to amantadine. However, in combination with segment 7 (M) of the sensitive strain, sensitivity is gradually lost. Recombinants of ts 3 (recombinants in which segment i of FPV is replaced by the corresponding gene of A2 Singapore, equi 2 or A3 Hong Kong) were relatively sensitive to amantadine in contrast to that obtained with A2 England, which was obtained without using ts 3. It is not clear whether ts 3 has a silent mutation in another gene which influences the amantadine resistance in these recombinants or whether the strain used for recombination determines the sensitivity or resistance to the drug in these instances.
DISCUSSION
It was shown by Appleyard (I 977), investigating human influenza strains, that amantadine resistance can be used as a genetic marker. He has also demonstrated that in the plaque reduction test this resistance cannot be transferred by the genes for haemagglutinin or neuraminidase alone. Many recombinants of known gene constellation between FPV and other influenza A strains of human or animal origin have been isolated in our laboratory (Scholtissek et al. 1976 ) . These recombinants were investigated to define a correlation between gene constellation and amantadine resistance. Although all of the 254 theoretically possible recombinants (2a--2) were not available, some useful conclusions can be drawn from the data presented.
When the resistance against amantadine was studied by two different tests the various parent strains behaved differently (Fig. I, Table 0 , e.g. by a single cycle experiment FPV was found to be highly sensitive, while in the plaque reduction and inhibition test (multiple cycle) it belonged to the resistant viruses. The A3 Hong Kong and equi 2 strains behaved the other way around. From this observation it might be concluded that amantadine has two different effects on virus replication, in which different virus products are involved. If this concept is correct, one should expect that the genetics of these two effects are different. Indeed, the correlation between gene constellation and transfer of resistance was different when two different tests were investigated. Concerning the single cycle test the gene products of RNA segments i, 2, 3, 5, 6 and 8 alone or in most combinations do not seem to be involved in amantadine resistance. The M protein (segment 7) does not seem to play a significant role in transferring resistance of the recombination pairs tested. Interestingly, gene products (combinations of segment 3 and 5) which are not part of the virus envelope can contribute, although weakly, to amantadine resistance. The haemagglutinin gene seems to play the most important role for transferring amantadine resistance, since all recombinants carrying segment 4 (HA) of the resistant strains are resistant, independent of the derivation of the other genes.
In the plaque reduction and inhibition test, however, some recombinants carrying the HA gene of the sensitive strains are sensitive against amantadine, while others are not (Table 4 ). This is in accordance with Appleyard's (I977) observation. In the plaque reduction and inhibition test the combination of segments 5 (NP) and 6 (NA) seems to be important for the transfer of sensitivity, and the presence of segment 7 (M) of the sensitive strain, in some instances at least, seems to counteract this effect. In this test, resistance of various recombinants with similar gene constellation seems to depend to a certain extent on the strain used for recombination.
In one aspect our results are at variance with those published by Appleyard (1977) . We found recombinants with intermediate sensitivity to amantadine when compared with the parent virus strains. In contrast, Appleyard found, with one exception, transfer of amantadine resistance as an all or nothing effect. This difference might be explained by the peculiar behaviour of FPV in the plaque reduction and inhibition test (see Table 2 ).
Our data are compatible with the concept that amantadine resistance or sensitivity is not confined to a single mechanism or a single gene product. Thus, it seems to be a general phenomenon that for certain biological activities of influenza viruses the gene constellation, that is, the fitting of several gene products, is responsible, as is also found for pathogenicity (Scholtissek et al. I977; Rottet al. I979 ) and host range (Scholtissek et al. 1978) .
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